RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses

Por Dolly, Saoirse O, Gurden, Mark D, Drosopoulos, Konstantinos, Clarke, Paul, de Bono, Johann, Kaye, Stan, Workman, Paul, Linardopoulos, Spiros
Publicado no Br J Cancer (2017)

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy

Por Dolly, Saoirse O, Migali, Cristina, Tunariu, Nina, Della-Pepa, Chiara, Khakoo, Shelize, Hazell, Steve, de Bono, Johann S, Kaye, Stanley B, Banerjee, Susana
Publicado no ESMO Open (2017)

A study of motivations and expectations of patients seen in phase 1 oncology clinics

Por Dolly, Saoirse O., Kalaitzaki, Eleftheria, Puglisi, Martina, Stimpson, Sarah, Hanwell, Janet, Fandos, Sonia Serrano, Stapleton, Sarah, Ansari, Thushara, Peckitt, Clare, Kaye, Stan, Lopez, Juanita, Yap, Timothy A., van der Graaf, Winette, de Bono, Johann, Banerji, Udai
Publicado no Cancer (2016)

Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

Por Dolly, Saoirse O., Wagner, Andrew J., Bendell, Johanna C., Kindler, Hedy L., Krug, Lee M., Seiwert, Tanguy Y., Zauderer, Marjorie G., Lolkema, Martijn P., Apt, Doris, Yeh, Ru-Fang, Fredrickson, Jill O., Spoerke, Jill M., Koeppen, Hartmut, Ware, Joseph A., Lauchle, Jennifer O., Burris, Howard A., de Bono, Johann S.
Publicado no Clin Cancer Res (2016)